Forbes J M & Co. LLP Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Forbes J M & Co. LLP boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 211.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,953 shares of the medical equipment provider’s stock after acquiring an additional 1,326 shares during the period. Forbes J M & Co. LLP’s holdings in Intuitive Surgical were worth $1,019,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Exome Asset Management LLC grew its stake in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. China Universal Asset Management Co. Ltd. increased its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the period. Finally, Consolidated Planning Corp raised its stake in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.9 %

Shares of ISRG opened at $582.98 on Friday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock has a market cap of $207.65 billion, a P/E ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. The company has a 50-day moving average of $554.85 and a two-hundred day moving average of $513.96.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ISRG. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, Royal Bank of Canada lifted their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,940 shares of company stock worth $3,333,485 in the last ninety days. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.